Development of a Dose Regimen for Obeticholic Acid in Patients with Primary Biliary Cholangitis and Hepatic Impairment

被引：0
|
作者：
Edwards, Jeffrey [1 ]
LaCerte, Carl [1 ]
Peyret, Thomas [2 ]
Gosselin, Nathalie H. [2 ]
Marier, J. F. [2 ]
机构：
[1] Intercept Pharmaceut Inc, San Diego, CA USA
[2] Pharsight, Princeton, NJ USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
296
引用
收藏
页码：167A / 167A
页数：1
相关论文
共 50 条
  • [31] Resolution of Jaundice in a Patient With Primary Biliary Cholangitis on Obeticholic Acid
    Barnhill, Michele
    Rangnekar, Amol
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1192 - S1192
  • [32] Obeticholic acid in primary biliary cholangitis: where we stand
    Manne, Vignan
    Kowdley, Kris V.
    CURRENT OPINION IN GASTROENTEROLOGY, 2019, 35 (03) : 191 - 196
  • [33] Management of primary biliary cholangitis prior to obeticholic acid availability
    Durazzo, Marilena
    Bonetto, Silvia
    Fagoonee, Sharmila
    Morgando, Anna
    Pellicano, Rinaldo
    MINERVA MEDICA, 2018, 109 (06) : 410 - 417
  • [34] Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis
    De Vincentis, Antonio
    Ampuero, Javier
    Terracciani, Francesca
    D'Amato, Daphne
    Gerussi, Alessio
    Cristoferi, Laura
    Cazzagon, Nora
    Bonaiuto, Emanuela
    Floreani, Annarosa
    Calvaruso, Vincenza
    Cadamuro, Luca
    Degasperi, Elisabetta
    Morgando, Anna
    Vanni, Ester
    Lleo, Ana
    Colapietro, Francesca
    Alvaro, Domenico
    Castellaneta, Antonino
    Labanca, Sara
    Vigano, Mauro
    Distefano, Marco
    Palitti, Valeria Pace
    Ricci, Chiara
    De Matthaeis, Nicoletta
    Marzioni, Marco
    Gomez-Dominguez, Elena
    Montero, Jose-Luis
    Molina, Esther
    Garcia-Buey, Luisa
    Casado, Marta
    Berenguer, Marina
    Conde, Isabel
    Simon, Miguel-Angel
    Fuentes, Javier
    Costa-Moreira, Pedro
    Macedo, Guilherme
    Jorquera, Francisco
    Morillas, Rosa-Maria
    Presa, Jose
    Sousa, Jose-Manuel
    Gomes, Dario
    Santos, Luis
    Olveira, Antonio
    Hernandez-Guerra, Manuel
    Aburruza, Leire
    Santos, Arsenio
    Carvalho, Armando
    Uriz, Juan
    Gutierrez, Maria-Luisa
    Perez, Elia
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (10) : 2062 - +
  • [35] OBETICHOLIC ACID TREATMENT IS ASSOCIATED WITH IMPROVED COLLAGEN MORPHOMETRY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
    Kremer, Andreas E.
    Bowlus, Christopher L.
    Bedossa, Pierre
    Pares, Albert
    Forman, Lisa M.
    Drenth, Joost P. H.
    Ryder, Stephen
    Terracciano, Luigi
    Jin, Yuying
    Liberman, Alexander
    Pencek, Richard
    MacConell, Leigh
    Pockros, Paul J.
    GUT, 2019, 68 : A110 - A111
  • [36] CHANGE IN BILIRUBIN WITH OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS PATIENTS WITH HIGH BASELINE BILIRUBIN
    Shapiro, David
    Hirschfield, Gideon
    Shiffman, Mitchell
    Pares, Albert
    Malecha, Elizabeth Smoot
    Pencek, Richard
    MacConell, Leigh
    GUT, 2018, 67 : A112 - A112
  • [37] REAL WORLD EFFECTIVENESS OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: THE GLOBAL EXPERIENCE
    Gulamhusein, Aliya F.
    Roberts, Surain B.
    Haliday, Neil
    Carbone, Marco
    D'Amato, Daphne
    Yimam, Kidist K.
    Namphuong Tran
    Floreani, Annarosa
    Cazzagon, Nora
    Kanagalingam, Gowthami
    Aziz, Bishoi
    Rupp, Christian
    Colapietro, Francisca
    Lleo, Ana
    Zigmond, Ehud
    Reig, Anna
    Pares, Albert
    Invernizzi, Pietro
    Mason, Andrew L.
    Thorburn, Douglas
    Hirschfield, Gideon M.
    Hansen, Bettina E.
    Trivedi, Palak
    HEPATOLOGY, 2020, 72 : 761A - 762A
  • [38] HEPATIC EVENTS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: 7 YEARS OF POST-MARKETING EXPERIENCE
    Levy, Cynthia
    Jones, Dave E.
    Ahmed, Islah
    Bessonova, Leona
    Wheeler, Darren
    Kryzhanovskaya, Ludmila
    Chiplin, Anne
    Buchanan-Peart, Keri-Ann
    Kowdley, Kris V.
    GASTROENTEROLOGY, 2024, 166 (05) : S1708 - S1709
  • [39] PREDICTION OF LIVER FAILURE IN CIRRHOTIC PRIMARY BILIARY CHOLANGITIS PATIENTS UNDER OBETICHOLIC ACID
    De Vincentis, Antonio
    D'Amato, Daphne
    Vigano, Mauro
    Marzioni, Marco
    Giannini, Edoardo G.
    Pompili, Maurizio
    Cazzagon, Nora
    Muratori, Luigi
    Lleo, Ana
    Calvaruso, Vincenza
    Marconi, Giulia
    Degasperi, Elisabetta
    Abenavoli, Ludovico
    Brunetto, Maurizia R.
    Vanni, Ester
    Colapietro, Francesca
    Pellicano, Rinaldo
    Romana Ponziani, Francesca
    Labanca, Sara
    Morgando, Anna
    Coco, Barbara
    Galati, Giovanni
    Morelli, Olivia
    Cannavo, Mariarita
    Chessa, Luchino
    Cuccorese, Giuseppe
    Russello, Maurizio
    Di Stefano, Marco
    Cozzolongo, Raffaele
    D'Anto, Maria
    Scifo, Gaetano
    Palitti, Valeria Pace
    Fontana, Rossana
    Niro, Grazia Anna
    Rosina, Floriano
    Pellicelli, Adriano
    Sacco, Rodolfo
    Saitta, Carlo
    Fiorini, Cecilia
    Zolfino, Teresa
    Storato, Silvia
    Simone, Loredana
    Marra, Fabio
    Picardi, Antonio
    Invernizzi, Pietro
    Claar, Ernesto
    Izzi, Antonio
    Vespasiani-Gentilucci, Umberto
    Carbone, Marco
    HEPATOLOGY, 2021, 74 : 775A - 776A
  • [40] SURVIVAL OF PATIENTS WITH DECOMPENSATED PRIMARY BILIARY CHOLANGITIS IN THE ERA OF OBETICHOLIC ACID AND MELD 3.0
    Sedki, Mai
    Chung, Nakia L.
    Goel, Aparna
    Montano-Loza, Aldo J.
    Kwong, Allison J.
    Sasaki, Kazunari
    Kim, W. Ray
    Mannalithara, Ajitha
    HEPATOLOGY, 2023, 78 : S2075 - S2076
12345